Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 320

Results For "NDA"

3522 News Found

GPT Healthcare to go public to fund expansion
Hospitals | October 18, 2021

GPT Healthcare to go public to fund expansion

The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India


Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore
Diagnostic Center | October 16, 2021

Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore

The revised deal involves a cash consideration only as against the earlier proposal of cash and equity


Govt launches `One Health’ surveillance programme
Public Health | October 15, 2021

Govt launches `One Health’ surveillance programme

The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens


AUM Biosciences closes US $ 27 million `Series A’ funding round
Startup | October 15, 2021

AUM Biosciences closes US $ 27 million `Series A’ funding round

Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate


Expect normal quarter in Q2FY22: Emkay
News | October 15, 2021

Expect normal quarter in Q2FY22: Emkay

Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report


Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Biotech | October 14, 2021

Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis

Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations


FICCI annual healthcare conference from Oct. 20-22nd 2021
Events | October 14, 2021

FICCI annual healthcare conference from Oct. 20-22nd 2021

This is a virtual event and the theme is `Transforming Healthcare beyond Covid’


IOL receives Korean FDA approval
Drug Approval | October 14, 2021

IOL receives Korean FDA approval

The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead


Roche’s 8-year safety data of Ocrevus shows reduced risk in multiple sclerosis patients
Biotech | October 13, 2021

Roche’s 8-year safety data of Ocrevus shows reduced risk in multiple sclerosis patients

New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials


Skanray to raise Rs 400 crore to fund its inorganic growth
News | October 12, 2021

Skanray to raise Rs 400 crore to fund its inorganic growth

Since its inception, the company has either acquired or taken a majority stake in five companies